Researchers in Austria are reporting the identification of a second strain of extensively drug-resistant (XDR) gonorrhea.
The World Health Organization (WHO) today issued a report highlighting the threat of healthcare-associated infections (HAIs) and the role that infection prevention and control (IPC) programs can play in reducing that threat.
Data suggest 4CMenB protection against gonorrhea and support the feasibility of a gonococcal vaccine.
The introduction of procalcitonin (PCT) testing at UK hospitals during the first wave of the COVID-19 pandemic was associated with an immediate but not sustained decline in antibiotic prescribing, researchers reported today in the Journal of Antimicrobial Chemotherapy.
A rapid, cartridge-based polymerase chain reaction (PCR) platform developed by scientists at Johns Hopkins University for detecting gonorrhea infections and providing antibiotic susceptibility results showed promising results in a study published this week in Science Translational Medicine.
An analysis of neighborhood-level data in three US cities highlights the racial and socioeconomic disparities in COVID-19 positivity, incidence, and mortality, researchers reported today in the Annals of Internal Medicine.
The European Commission this week published its latest annual progress report on implementation of the European One Health Action Plan against Antimicrobial Resistance (AMR).
A paper today in Morbidity and Mortality Weekly Reports (MMWR) describes the first US case of Neisseria gonorrhoeae harboring a genetic element that confers resistance to a first-line antibiotic.
CARB-X announced today that it is awarding $2.86 million to Microbiotix of Worcester, Massachusetts, to develop a new oral antibiotic for multidrug-resistant (MDR) gonorrhea.
Nearly one in five antibiotic prescriptions for hospitalized children in Australia is inappropriate, Australian researchers reported yesterday in the Journal of Antimicrobial Chemotherapy.